Dendreon (DNDN) Spikes On Presentation News

As discussed, the spike higher in Dendreon Corp. (Nasdaq: DNDN) is related to word that results from the company's prostate cancer drug PROVENGE will be presented at the American Urological Association meeting on Tuesday, April 28. Here is a link to the page announcing the event.

Shares of the often-volatile Dendreon are up 29% on the news. With the crazy trading in this stock, all those gains can be given up in the blink of an eye or it could be up 100% if the "Dendreonians" can get the hype-machine going.

You May Also Be Interested In

• PG&E Corp, Edison Spike; California Assembly Won't Take Vote On Utility Wildfire Bill
• Apple (AAPL) sets John Ternus' salary at $3M
• NVIDIA (NVDA) Said To Near $14 bln Deal For Hugging Face This Week - Bloomberg